(Q41531899)

2 October 2017

Homologous C3 deposition and homotypic cell adhesion in a human myeloid cell line, P39. (English)

1 reference

2 October 2017

1 reference

Matsumoto M

1

1 reference

PubMed ID

8103747

2 October 2017

Seya T

series ordinal

2

1 reference

PubMed ID

8103747

2 October 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

European Journal of Immunology

2 October 2017

1 reference

2 October 2017

23

1 reference

2 October 2017

9

1 reference

2 October 2017

2270-2278

1 reference

Functional properties of membrane cofactor protein of complement

2 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

Enhancement of Lymphocyte-Mediated K562 Cytotoxicity by Antibodies against Complement Membrane Cofactor Protein (CD46) and Decay-Accelerating Factor (CD55)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

Complement and bacteria: chemistry and biology in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Evidence for presence of an internal thiolester bond in third component of human complement.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Alternative complement pathway-mediated myeloid cell cytotoxicity: Repertoire of membrane factors participating in regulation of C3 deposition and cytolysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Malignant cells isolated from Burkitt's lymphoma but not other forms of leukemia activate the alternative complement pathway in human serum.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

HIV and HIV-infected cells differentially activate the human complement system independent of antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Mechanism of action of the C3b inactivator: Requiremen for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b′)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Homotypic cell aggregations of human myeloma cells with ICAM-1 and LFA-1 molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Regulatory system of guinea-pig complement C3b: Tests for compatibility of guinea-pig factors H and I with human factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Separation of self from non-self in the complement system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Restriction of alternative complement pathway activation by sialosylglycolipids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Interferon amplifies complement activation by Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Activation and Fixation of C3 by Human B Cell Lines Is Enhanced by Interferon-Gamma and Tumor Necrosis Factor Alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Supergene families meet in the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

The regulators of complement activation (RCA) gene cluster

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230933

7 January 2021

Identifiers

DOI

10.1002/EJI.1830230933

1 reference

2 October 2017

1 reference

PubMed ID

8103747